BiotechTube
Home/DermBiont/Emma Taylor, MD
ET

Emma Taylor, MD

Advisor, Dermatology

DermBiont

Therapeutic Areas

DermatologyHyperpigmentation Disorders

DermBiont Pipeline

DrugIndicationPhase
SM-030Melasma and other hyperpigmentation disorders of the skinUnknown

Leadership Team at DermBiont

KB
Karl Beutner, MD, PhD
Chief Executive Officer, Co-founder
N(
Nichola (Nick) Eliovits
Chief Financial Officer, Co-founder
MN
Max N. Dawson
Chief Operating Officer
View full DermBiont profile